Supplemental material
Open access
1,179
Views
1
CrossRef citations to date
0
Altmetric
Influenza
Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
Eliel Nhama Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Hye Seonga Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Hakjun Hyuna Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Jin Gu Yoona Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Ji Yun Noha Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Hee Jin Cheonga Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Woo Joo Kima Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaView further author information
, Eugene Kimc Market Access, Syneos Health Korea, Seoul, KoreaView further author information
, Leejung Choic Market Access, Syneos Health Korea, Seoul, KoreaView further author information
, Jung-Min Leed Sanofi Korea, Seoul, KoreaView further author information
& Joon Young Songa Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;b RWE, Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Republic of KoreaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2266233
|
Received 24 Apr 2023, Accepted 29 Sep 2023, Published online: 15 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.